Abstract
Advanced gastroesophageal cancer is a devastating disease with poor outcome. Due to symptoms such as dysphagia and weight loss, patients often suffer from nutritional deficits. However, the potential impact of circulating nutritional biomarkers on the overall survival (OS) is not fully understood. Thus, the aim of this analysis was to investigate the prognostic potential of circulating nutritional biomarkers in a large European cohort of stage IV gastroesophageal cancer patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
